Invest Green SPAC Targets $150M IPO Amid Dilution, Conflict Concerns

TL;DR

**Avoid IGACR; the sponsor's massive founder share discount and inherent conflicts of interest make this a high-risk gamble for public shareholders.**

AI Summary

Invest Green Acquisition Corp (IGACR) filed an S-1/A on November 4, 2025, for an initial public offering of 15,000,000 units at $10.00 per unit, aiming to raise $150,000,000. Each unit comprises one Class A ordinary share and one right to receive one-tenth of a Class A ordinary share upon business combination. The sponsor, IG SPAC Sponsor LLC, committed to purchasing 480,000 private placement units for $2,400,000, and underwriters will purchase 300,000 private placement units for $1,500,000. The company is a blank check company seeking a business combination within 24 months, with potential extensions up to 36 months. Public shareholders face immediate and substantial dilution due to the sponsor's nominal purchase price of $25,000 for 5,750,000 founder shares. The filing highlights significant conflicts of interest for management and the sponsor, who could profit even if the target business declines in value for public shareholders. Up to $500,000 in loans from the sponsor will be repaid, and up to $3,500,000 in future working capital loans may convert into units at $5.00 each, potentially causing further dilution.

Why It Matters

This S-1/A filing is crucial for investors as it details the structure of Invest Green Acquisition Corp's $150 million IPO, a blank check company with no current operations. The significant dilution risk for public shareholders, stemming from the sponsor's nominal $25,000 investment for 5,750,000 founder shares, directly impacts potential returns. Employees and customers of a future target company could be affected by the sponsor's incentive to complete a deal, even if it's not optimal, due to potential conflicts of interest. In the competitive SPAC market, these structural risks and conflicts could deter sophisticated investors, making it harder for IGACR to find a high-quality target and potentially impacting the broader market's perception of SPAC integrity.

Risk Assessment

Risk Level: high — The risk level is high due to the substantial dilution faced by public shareholders, as the sponsor acquired 5,750,000 founder shares for a nominal $25,000. This creates a significant incentive for the sponsor to complete a business combination, even if it's unprofitable for public shareholders, as they could still make a substantial profit. Additionally, potential conflicts of interest exist where officers and directors may have obligations to other entities, and up to $3,500,000 in working capital loans from the sponsor could convert into units at $5.00, further diluting public shareholders.

Analyst Insight

Investors should exercise extreme caution and thoroughly evaluate the significant dilution and conflict of interest risks before considering an investment in IGACR. Given the sponsor's low cost basis and the potential for further dilution from convertible loans, it would be prudent to wait until a definitive business combination target is identified and its terms are fully disclosed, allowing for a more informed assessment of value and risk.

Financial Highlights

debt To Equity

N/A

revenue

$0

operating Margin

N/A

total Assets

$0

total Debt

$0

net Income

$0

eps

$0

gross Margin

N/A

cash Position

$0

revenue Growth

N/A

Key Numbers

• $150,000,000 — Total Public Offering Price (Amount to be raised from the IPO of 15,000,000 units)
• $10.00 — Public Offering Price Per Unit (Price for each unit in the initial public offering)
• 15,000,000 — Units Offered (Number of units available in the initial public offering)
• $2,400,000 — Sponsor Private Placement Investment (Amount IG SPAC Sponsor LLC committed to purchase in private placement units)
• 480,000 — Sponsor Private Placement Units (Number of private placement units purchased by IG SPAC Sponsor LLC)
• $1,500,000 — Underwriter Private Placement Investment (Amount underwriters committed to purchase in private placement units)
• 300,000 — Underwriter Private Placement Units (Number of private placement units purchased by underwriters)
• $25,000 — Sponsor Founder Share Purchase Price (Nominal price paid by sponsor for 5,750,000 founder shares)
• 5,750,000 — Founder Shares Held by Sponsor (Number of Class B ordinary shares held by IG SPAC Sponsor LLC after surrender)
• 24 months — Time to Consummate Business Combination (Initial period from closing of offering to complete a business combination)

Key Players & Entities

• Invest Green Acquisition Corporation (company) — Registrant for S-1/A filing
• IG SPAC Sponsor LLC (company) — Sponsor of Invest Green Acquisition Corporation
• Andrew McLean (person) — Chief Executive Officer of Invest Green Acquisition Corporation
• Alan Annex, Esq. (person) — Counsel from Greenberg Traurig, LLP
• Jason Simon, Esq. (person) — Counsel from Greenberg Traurig, LLP
• Tricia Branker, Esq. (person) — Counsel from Greenberg Traurig, LLP
• Hayden Isbister (person) — Counsel from Mourant Ozannes (Cayman) LLP
• Stephen C. Ashley, Esq. (person) — Counsel from Pillsbury Winthrop Shaw Pittman LLP
• Continental Stock Transfer and Trust Company (company) — Trustee for the U.S.-based trust account
• Cohen & Company Capital Markets (company) — Representative of the underwriters

FAQ

Risk Factors

• Redemption Risk [high — financial]: A significant portion of the public shares may be redeemed by shareholders if the business combination does not meet their expectations or if market conditions are unfavorable. This could deplete the cash available for the business combination, potentially jeopardizing the transaction.
• Dilution from Sponsor and Underwriter Units [high — financial]: The sponsor and underwriters are purchasing units at a nominal price relative to the public offering price, and founder shares are acquired at a very low cost. This structure inherently dilutes public shareholders' ownership and potential returns.
• Conversion of Working Capital Loans [medium — financial]: Future working capital loans from the sponsor, up to $3,500,000, can convert into units at $5.00 per unit. This conversion can lead to substantial additional dilution for public shareholders, especially if the conversion occurs at a price significantly below the initial offering price.
• Sponsor Loan Repayment [low — financial]: The company may repay up to $500,000 in loans from the sponsor. While this is a repayment of debt, it reduces the capital available for the business combination if not managed carefully.
• Failure to Consummate Business Combination [high — operational]: The company has a limited timeframe of 24 months (extendable to 36 months) to identify and complete a business combination. Failure to do so will result in liquidation, and public shareholders will not realize any return on their investment.
• Conflicts of Interest [high — legal]: Management and the sponsor have potential conflicts of interest, as they may profit from the transaction even if the target business's value declines for public shareholders. This misalignment could influence decision-making.
• Market Volatility [medium — market]: The success of the business combination and the subsequent performance of the combined entity are subject to general market conditions and investor sentiment, which can be volatile.
• SEC Scrutiny and Disclosure Requirements [medium — regulatory]: As a blank check company, IGACR is subject to stringent SEC regulations and disclosure requirements. Any misstatements or omissions in filings could lead to regulatory action and reputational damage.

Industry Context

The Special Purpose Acquisition Company (SPAC) market has seen significant activity, driven by companies seeking alternative routes to public markets. However, increased regulatory scrutiny and market volatility have led to a more cautious environment. SPACs are increasingly being evaluated on their ability to execute timely and value-accretive business combinations, with a focus on sponsor alignment and potential dilution.

Regulatory Implications

Invest Green Acquisition Corp, as a SPAC, faces heightened regulatory oversight from the SEC. The S-1/A filing is subject to review, and any inaccuracies or omissions could lead to enforcement actions. The structure of the offering, including founder shares and private placements, is under scrutiny for potential investor protection issues.

What Investors Should Do

1. Scrutinize the sponsor's incentives and potential conflicts of interest.
2. Assess the potential for dilution from founder shares, private placement units, and convertible loans.
3. Evaluate the company's ability to identify and complete a suitable business combination within the 24-month timeframe.
4. Understand the implications of redemption rights on the available capital for a business combination.
5. Monitor the sponsor's potential future capital injections and their conversion terms.

Key Dates

• 2025-11-04: S-1/A Filing — Initiated the IPO process, providing detailed information about the company's structure, offering, and risks.

Glossary

Blank Check Company

A shell corporation that is set up to acquire a private company, thus becoming a publicly traded entity. Also known as a Special Purpose Acquisition Company (SPAC). (IGACR is structured as a blank check company, indicating its primary purpose is to find and merge with an operating business.)

Units

A security that combines two or more different securities, typically a stock and a warrant or right, into a single package. (The IPO offers units, each containing one Class A ordinary share and one-tenth of a right, which impacts the overall capital structure and potential future share count.)

Rights

A type of security that gives the holder the right, but not the obligation, to purchase additional securities (in this case, Class A ordinary shares) at a specified price and within a specified timeframe. (The rights included in the units can lead to future dilution if exercised, as they represent potential future share issuances.)

Founder Shares

Shares issued to the sponsor or founders of a SPAC before the IPO, typically at a nominal price, and often carrying more voting rights or subject to different vesting conditions. (The sponsor's acquisition of 5,750,000 founder shares for $25,000 highlights significant dilution for public investors.)

Private Placement Units

Units purchased by the sponsor and underwriters concurrently with the IPO, often at the same unit price but with different share/right compositions or lock-up periods. (These units represent a significant portion of the capital structure and are acquired by parties closely associated with the SPAC, impacting dilution.)

Business Combination

The merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business transaction between the SPAC and one or more target businesses. (This is the sole objective of IGACR; failure to complete one within the specified timeframe leads to liquidation.)

Redemption

The right of public shareholders to have their shares redeemed for cash at a specified price (typically the IPO price) if they do not approve of the proposed business combination. (High redemption rates can deplete the cash available for the business combination, potentially derailing the transaction.)

Working Capital Loans

Loans provided by the sponsor or affiliated parties to cover initial operating expenses before the business combination is completed. (These loans can be converted into units, potentially causing further dilution to public shareholders.)

Year-Over-Year Comparison

As this is an S-1/A filing for an initial public offering, there is no prior year financial data or previous filing to compare against. The document outlines the proposed structure, offering details, and risk factors for the first time.

Key Financial Figures

• $150,000,000 — TO COMPLETION, DATED NOVEMBER 4, 2025 $150,000,000 Invest Green Acquisition Corporation
• $10.00 — ies. Each unit has an offering price of $10.00 and consists of one Class A ordinary sh
• $500,000 — ring or thereafter, we will repay up to $500,000 in loans made to us by our sponsor to c
• $3,500,000 — our initial business combination, up to $3,500,000 of such loans may be convertible into u
• $5.00 — be convertible into units at a price of $5.00 per unit at the option of the lender, w
• $100,000 — thereon (net of taxes payable and up to $100,000 of interest income to pay dissolution e
• $0.20 — 000,000 ____________ (1) Includes (a) $0.20 per unit, or $3,000,000 in the aggregat
• $3,000,000 — __ (1) Includes (a) $0.20 per unit, or $3,000,000 in the aggregate (or $3,450,000 if the
• $3,450,000 — nit, or $3,000,000 in the aggregate (or $3,450,000 if the overallotment option is exercise
• $0.10 — closing of this offering, of which (i) $0.10 per unit if the overallotment option is
• $1,500,000 — erallotment option is not exercised (or $1,500,000 (whether or not the overallotment optio
• $1,950,000 — ion is not exercised (or $1,500,000 (or $1,950,000 if the overallotment option is exercise
• $0.40 — n is exercised in full)); and (b) up to $0.40 per unit, or up to $6,000,000 in the ag
• $6,000,000 — and (b) up to $0.40 per unit, or up to $6,000,000 in the aggregate (or up to $6,900,000 i
• $6,900,000 — o $6,000,000 in the aggregate (or up to $6,900,000 if the overallotment option is exercise

Filing Documents

• ea0247296-05.htm (S-1/A) — 4221KB
• ea024729605ex1-1_invest.htm (EX-1.1) — 273KB
• ea024729605ex10-9_invest.htm (EX-10.9) — 27KB
• ea024729605ex23-1_invest.htm (EX-23.1) — 4KB
• 0001213900-25-106275.txt ( ) — 7800KB
• ck0002075068-20251104.xsd (EX-101.SCH) — 9KB
• ck0002075068-20251104_def.xml (EX-101.DEF) — 16KB
• ck0002075068-20251104_lab.xml (EX-101.LAB) — 131KB
• ck0002075068-20251104_pre.xml (EX-101.PRE) — 75KB
• ea0247296-05_htm.xml (XML) — 1096KB

Risk Factors

Risk Factors 44 Cautionary Note Regarding Forward-Looking Statements 87

Use of Proceeds

Use of Proceeds 88 Dividend Policy 91

Dilution

Dilution 92 Capitalization 94

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 95 Proposed Business 101 Effecting Our Initial Business Combination 116 Management 135 Principal Shareholders 146 Certain Relationships and Related Party Transactions 151

Description of Securities

Description of Securities 154 Taxation 172

Underwriting

Underwriting 182 Legal Matters 190 Experts 190 Where You Can Find Additional Information 190 Index to Financial Statements F-1 We are responsible for the information contained in this prospectus. We have not, and the underwriters have not, authorized anyone to provide you with information that is different from or inconsistent with that contained in this prospectus. We are not, and the underwriters are not, making an offer to sell securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this prospectus is accurate as of any date other than the date on the front of this prospectus. Trademarks This prospectus contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus may appear without the or symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies' trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. i Table of Contents Summary This summary only highlights the more detailed information appearing elsewhere in this prospectus. As this is a summary, it does not contain all of the information that you should consider in making an investment decision. You should read this entire prospectus carefully, including the information under "Risk Factors" and our financial statements and the related notes included elsewhere in this prospectus, before investing. Unless otherwise stated in this prospectus or the context otherwise requires, references to: "CCM" are to Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, representative of the underwriters in this offering; "

View Full Filing

View this S-1/A filing on SEC EDGAR